Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target
Author:
Smati SarraORCID, Polizzi Arnaud, Fougerat Anne, Ellero-Simatos Sandrine, Blum Yuna, Lippi Yannick, Régnier Marion, Laroyenne Alexia, Huillet Marine, Arif Muhammad, Zhang Cheng, Lasserre Frederic, Marrot Alain, Al Saati Talal, Wan JingHong, Sommer Caroline, Naylies Claire, Batut Aurelie, Lukowicz Celine, Fougeray Tiffany, Tramunt Blandine, Dubot Patricia, Smith Lorraine, Bertrand-Michel Justine, Hennuyer Nathalie, Pradere Jean-Philippe, Staels BartORCID, Burcelin RemyORCID, Lenfant Françoise, Arnal Jean-François, Levade Thierry, Gamet-Payrastre Laurence, Lagarrigue Sandrine, Loiseau Nicolas, Lotersztajn Sophie, Postic Catherine, Wahli WalterORCID, Bureau Christophe, Guillaume Maeva, Mardinoglu Adil, Montagner AlexandraORCID, Gourdy PierreORCID, Guillou HervéORCID
Abstract
ObjectiveWe evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD). We investigated diet-induced phenotypic responses to define sex-specific regulation between healthy liver and NAFLD to identify influential pathways in different preclinical murine models and their relevance in humans.DesignDifferent models of diet-induced NAFLD (high-fat diet, choline-deficient high-fat diet, Western diet or Western diet supplemented with fructose and glucose in drinking water) were compared with a control diet in male and female mice. We performed metabolic phenotyping, including plasma biochemistry and liver histology, untargeted large-scale approaches (liver metabolome, lipidome and transcriptome), gene expression profiling and network analysis to identify sex-specific pathways in the mouse liver.ResultsThe different diets induced sex-specific responses that illustrated an increased susceptibility to NAFLD in male mice. The most severe lipid accumulation and inflammation/fibrosis occurred in males receiving the high-fat diet and Western diet, respectively. Sex-biased hepatic gene signatures were identified for these different dietary challenges. The peroxisome proliferator-activated receptor α (PPARα) co-expression network was identified as sexually dimorphic, and in vivo experiments in mice demonstrated that hepatocyte PPARα determines a sex-specific response to fasting and treatment with pemafibrate, a selective PPARα agonist. Liver molecular signatures in humans also provided evidence of sexually dimorphic gene expression profiles and the sex-specific co-expression network for PPARα.ConclusionsThese findings underscore the sex specificity of NAFLD pathophysiology in preclinical studies and identify PPARα as a pivotal, sexually dimorphic, pharmacological target.Trial registration numberNCT02390232.
Funder
Agence Nationale de la Recherche Joint Programming Initiative A healthy diet for a healthy life Région Occitanie Institut National de la Santé et de la Recherche Médicale Agreenskills Société Française de Nutrition Société Francophone du Diabète Société Nationale Française de Gastro-Entérologie Association Française pour l'Etude du Foie
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|